Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease
Crossref DOI link: https://doi.org/10.1007/s00392-017-1172-4
Published Online: 2017-11-03
Published Print: 2018-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Emrich, Insa E.
Zawada, Adam M.
Martens-Lobenhoffer, Jens
Fliser, Danilo
Wagenpfeil, Stefan
Heine, Gunnar H.
Bode-Böger, Stefanie M.
License valid from 2017-11-03